Female sex was associated with a lower risk of 30-day or in-hospital permanent pacemaker implantation after TAVI compared to men (14.9% vs 16.6%; OR 0.90; 95% CI 0.84-0.96; P=0.0022).
Meta-Analysis (n=70,313)
Yes
Does female sex reduce the risk of 30-day or in-hospital permanent pacemaker implantation in patients undergoing TAVI?
Female sex is associated with a 10% relative reduction in the odds of requiring a permanent pacemaker after TAVI compared to male sex, though this advantage is attenuated with balloon-expandable devices.
Odds Ratio: 0.9 (95% CI 0.84–0.96)
Absolute Event Rate: 14.9% vs 16.6%
p-value: p=0.0022
Background Limited clinical evidence and literature are available about the potential impact of sex on permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI). The aim of this work was to evaluate the relationship between sexes and atrioventricular conduction disturbances requiring PPI after TAVI. Methods and Results Data were obtained from 46 studies from PubMed reporting information about the impact of patient sex on PPI after TAVI. Total proportions with 95% Cls were reported. Funnel plot and Egger test were used for estimation of publication bias. The primary end point was 30‐day or in‐hospital PPI after TAVI, with odds ratios and 95% CIs extracted. A total of 70 313 patients were included, with a cumulative proportion of 51.5% of women (35 691 patients; 95% CI, 50.2–52.7). The proportion of women undergoing TAVI dropped significantly over time ( P <0.0001). The cumulative PPI rate was 15.6% (95% CI, 13.3–18.3). The cumulative rate of PPI in women was 14.9% (95% CI, 12.6–17.6), lower than in men (16.6%; 95% CI, 14.2–19.4). The risk for post‐TAVI PPI was lower in women (odds ratio, 0.90; 95% CI, 0.84–0.96 P =0.0022). By meta‐regression analysis, age ( P =0.874) and ventricular function ( P =0.302) were not significantly associated with PPI among the sexes. Balloon‐expandable TAVI significantly decrease the advantage of women for PPI, approaching the same rate as in men ( P =0.0061). Conclusions Female sex is associated with a reduced rate of PPI after TAVI, without influence of age or ventricular function. Balloon‐expandable devices attenuate this advantage in favor of women. Additional investigations are warranted to elucidate sex‐based differences in developing conduction disturbances after TAVI.
Ravaux et al. (Sat,) conducted a meta-analysis in Transcatheter aortic valve implantation (TAVI) (n=70,313). Female sex vs. Male sex was evaluated on 30-day or in-hospital permanent pacemaker implantation (PPI) after TAVI (OR 0.90, 95% CI 0.84-0.96, p=0.0022). Female sex was associated with a lower risk of 30-day or in-hospital permanent pacemaker implantation after TAVI compared to men (14.9% vs 16.6%; OR 0.90; 95% CI 0.84-0.96; P=0.0022).